About this product

This Antipyretic Antiviral Premix is specifically formulated for the initial stages of sores and carbuncles, targeting symptoms such as obvious local redness, swelling, heat, and pain. Its primary function is to combat the inflammatory and viral aspects of these conditions, offering a targeted therapeutic solution. While specific technical specifications and performance characteristics are not detailed, its efficacy in addressing early-stage symptoms suggests a potent formulation designed for rapid action. The premix is likely manufactured under stringent quality control processes to ensure purity and effectiveness, though specific material compositions and construction quality details are not provided. This product is available in a premix form, indicating it is intended for further processing or incorporation into final pharmaceutical or veterinary products, with customisation options potentially available upon inquiry. Typical applications include its use in the formulation of topical treatments or oral medications for human or animal health, serving industries focused on pharmaceuticals, veterinary medicine, and personal care. Target buyers include pharmaceutical manufacturers, veterinary product wholesalers, and potentially specialized retailers seeking advanced formulations. While no specific quality standards or certifications are mentioned, its intended use in health-related applications implies adherence to relevant industry regulations. This product is suitable for international trade buyers seeking effective, specialized premixes for the treatment of common skin ailments, offering a concentrated solution for formulation into a range of end products.